Parotid Gland Biopsy as an Additional Diagnostic Tool for Supporting the Diagnosis of Sjögren's Syndrome [0.03%]
腮腺活检作为辅助诊断工具在干燥综合征诊断中的应用价值分析
Muhammad S Soyfoo,Xavier Catteau,Christine Delporte
Muhammad S Soyfoo
Sjögren's syndrome (SS) is an autoimmune disease characterized by keratoconjunctivitis sicca and xerostomia. There are actually no diagnostic criteria for SS, but classification criteria based on the revised American-European criteria have...
Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids [0.03%]
葡糖胺及骨胶原 sulfate 对OA软骨代谢的影响：特别注重Omega-3脂肪酸等其他营养补充的搭配效果展望
Jörg Jerosch
Jörg Jerosch
Osteoarthritis (OA) is a degenerative joint disease that is characterized by increasing loss of cartilage, remodeling of the periarticular bone, and inflammation of the synovial membrane. Besides the common OA therapy with nonsteroidal anti...
B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence [0.03%]
系统性硬化症中B细胞去耗竭疗法：实验依据及临床证据更新
Dimitrios Daoussis,Stamatis-Nick C Liossis,Georgios Yiannopoulos et al.
Dimitrios Daoussis et al.
Systemic sclerosis (SSc) is a systemic rheumatic disease with poor prognosis since therapeutic options are limited. Recent evidence from animal models suggests that B-cells may be actively involved in the fibrotic process. B-cells from tigh...
Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway [0.03%]
挪威轴性脊柱炎患者使用艾托考昔与塞来昔布及非选择性NSAIDs治疗的 cost-effectiveness 分析
Jeroen P Jansen,Stephanie D Taylor
Jeroen P Jansen
Objectives. To evaluate the cost-effectiveness of etoricoxib (90 mg) relative to celecoxib (200/400 mg), and the nonselective NSAIDs naproxen (1000 mg) and diclofenac (150 mg) in the initial treatment of ankylosing spondylitis in Norway. Me...
Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis [0.03%]
核激素受体PPARα激动剂作为治疗类风湿性关节炎的潜在疾病修正药物
Ivan V Shirinsky,Valery S Shirinsky
Ivan V Shirinsky
In recent years, peroxisome proliferator-activated receptors (PPARs) have received growing interest due to the broad spectrum of their biological activities. PPARα, an isoform of PPAR, plays an important role in lipid homeostasis and infla...
Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis [0.03%]
风湿性关节炎的联合抗生素疗法的随机双盲试验
Angela Smith,Caroline Doré,Peter Charles et al.
Angela Smith et al.
Objective. A combination of intravenous clindamycin and oral tetracycline has been used for many years as a treatment for active rheumatoid arthritis (RA), despite the absence of good evidence for its efficacy. A single-blind pilot study of...
A child with x-linked agammaglobulinemia and enthesitis-related arthritis [0.03%]
一名患X连锁低丙球血症和附着点相关性关节炎的患儿
Sukesh Sukumaran,Katherine Marzan,Bracha Shaham et al.
Sukesh Sukumaran et al.
X-linked agammaglobulinemia (XLA) is a primary immune deficiency characterized by recurrent bacterial infections and profoundly depressed serum immunoglobulin levels and circulating mature B cells. We describe a 12-year-old boy with XLA and...
Surgical management of temporomandibular joint ankylosis in ankylosing spondylitis [0.03%]
强直性脊柱炎颞下颌关节强直的外科治疗
Andrew M Felstead,Peter J Revington
Andrew M Felstead
Relatively few patients develop such severe degenerative temporomandibular joint (TMJ) disease that they require total joint replacement. Current indications include those conditions involving condylar bone loss such as degenerative (osteoa...
Mahnaz Momeni,Nora Taylor,Mahsa Tehrani
Mahnaz Momeni
Ankylosing spondylitis is a chronic inflammatory condition that usually affects young men. Cardiac dysfunction and pulmonary disease are well-known and commonly reported extra-articular manifestation, associated with ankylosing spondylitis ...
Antony N Antoniou,Izabela Lenart,David B Guiliano
Antony N Antoniou
The association between HLA-B27 and the group of autoimmune inflammatory arthritic diseases, the spondyloarthropathies (SpAs) which include ankylosing spondylitis (AS) and Reactive Arthritis (ReA), has been well established and remains the ...